Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Return on Assets (2016 - 2026)

Pharma-Bio Serv (PBSV) has disclosed Return on Assets for 13 consecutive years, with 0.03% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Assets rose 2.0% year-over-year to 0.03%, compared with a TTM value of 0.03% through Oct 2025, up 2.0%, and an annual FY2025 reading of 0.01%, up 4.0% over the prior year.
  • Return on Assets was 0.03% for Q4 2025 at Pharma-Bio Serv, down from 0.03% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.1% in Q3 2021 and bottomed at 0.2% in Q3 2022.
  • Average Return on Assets over 5 years is 0.01%, with a median of 0.02% recorded in 2024.
  • The sharpest move saw Return on Assets dropped -30bps in 2022, then rose 27bps in 2023.
  • Year by year, Return on Assets stood at 0.08% in 2021, then skyrocketed by 168bps to 0.05% in 2022, then increased by 8bps to 0.06% in 2023, then crashed by -181bps to 0.05% in 2024, then surged by 38bps to 0.03% in 2025.
  • Business Quant data shows Return on Assets for PBSV at 0.03% in Q4 2025, 0.03% in Q3 2025, and 0.03% in Q2 2025.